Iranian nationals no longer eligible for E1, E2 trade and investment visas, USCIS says

  • 📰 Newsweek
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 52%

Ireland News News

Ireland Ireland Latest News,Ireland Ireland Headlines

The change comes following the U.S.'s October 3, 2018, termination of the 1955 Treaty of Amity, Economic Relations, and Consular Rights with Iran.

Iranian nationals will no longer be eligible for E-1 and E-2 trade and investment visas, the U.S. Citizenship and Immigration Services agency announced on Wednesday.

Given that"E-1 and E-2 nonimmigrant visas are based on trade and investment treaties or specific legislation providing for reciprocal treatment of the respective countries' nationals," USCIS said,"the existence of a qualifying treaty or authorizing legislation is therefore a threshold requirement for issuing an E visa."

"Accordingly, a national of Iran is no longer eligible for an extension of stay in E-1 or E-2 status or a change of status to E-1 or E-2 on the basis of the Treaty of Amity," Koumans said. Koumans made clear, however, that"the changes described in this notice do not prevent Iranian nationals and their dependents from seeking admission in, or applying for a grant of, another nonimmigrant visa classification for which they believe they can establish eligibility under U.S. immigration law."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 468. in İE
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

“I stand with the Iranian people”

Ireland Ireland Latest News, Ireland Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The Global Mental Health Crisis Requires a Worldwide Investment, Advocates SayThe Global Mental Health Crisis Requires a Worldwide Investment, Advocates Say On TIME Davos Panel
Source: TIMEHealth - 🏆 121. / 63 Read more »